-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Orion Portfolio Solutions LLC Purchases Shares of 30,796 BeyondSpring Inc. (NASDAQ:BYSI)
Orion Portfolio Solutions LLC Purchases Shares of 30,796 BeyondSpring Inc. (NASDAQ:BYSI)
Orion Portfolio Solutions LLC purchased a new stake in BeyondSpring Inc. (NASDAQ:BYSI – Get Rating) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 30,796 shares of the company's stock, valued at approximately $44,000. Orion Portfolio Solutions LLC owned 0.08% of BeyondSpring as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also recently added to or reduced their stakes in the business. Decheng Capital Management III Cayman LLC acquired a new position in BeyondSpring in the first quarter valued at approximately $10,908,000. BlackRock Inc. raised its position in shares of BeyondSpring by 20.8% during the first quarter. BlackRock Inc. now owns 1,861,219 shares of the company's stock worth $4,095,000 after purchasing an additional 320,428 shares during the period. State Street Corp raised its position in shares of BeyondSpring by 11.5% during the first quarter. State Street Corp now owns 563,670 shares of the company's stock worth $1,240,000 after purchasing an additional 57,933 shares during the period. Renaissance Technologies LLC raised its position in shares of BeyondSpring by 831.9% during the first quarter. Renaissance Technologies LLC now owns 282,373 shares of the company's stock worth $621,000 after purchasing an additional 252,073 shares during the period. Finally, BNP Paribas Arbitrage SA raised its position in shares of BeyondSpring by 19.6% during the first quarter. BNP Paribas Arbitrage SA now owns 131,477 shares of the company's stock worth $289,000 after purchasing an additional 21,587 shares during the period. 23.35% of the stock is owned by institutional investors and hedge funds.
Get BeyondSpring alerts:BeyondSpring Stock Down 4.4 %
Shares of NASDAQ:BYSI opened at $0.97 on Wednesday. BeyondSpring Inc. has a twelve month low of $0.94 and a twelve month high of $17.98. The stock's 50 day moving average is $1.40 and its 200-day moving average is $1.62. The firm has a market capitalization of $37.95 million, a price-to-earnings ratio of -0.59 and a beta of 1.03.
About BeyondSpring
(Get Rating)BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer.
Featured Stories
- Get a free copy of the StockNews.com research report on BeyondSpring (BYSI)
- Defensive Stocks For A Volatile Market
- SunPower Is Ready To Power Up Triple-Digit Earnings Gains
- Will UPS Be Next to Deliver a Warning?
- Is This the Darkest Before the Dawn for Gap Stock?
- Build A Better Tech Portfolio With Jabil Inc.
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
Orion Portfolio Solutions LLC purchased a new stake in BeyondSpring Inc. (NASDAQ:BYSI – Get Rating) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 30,796 shares of the company's stock, valued at approximately $44,000. Orion Portfolio Solutions LLC owned 0.08% of BeyondSpring as of its most recent filing with the Securities & Exchange Commission.
根据猎户投资组合有限责任公司(Orion Portfolio Solutions LLC)提交给美国证券交易委员会(Securities&Exchange Commission)的最新Form 13F文件,该公司在第二季度增持了万春医药(Form 13F)的股份。该基金购买了30,796股该公司股票,价值约44,000美元。根据新浪万春医药最近提交给美国证券交易委员会的文件,猎户座投资组合有限责任公司持有美团0.08%的股份。
Several other institutional investors have also recently added to or reduced their stakes in the business. Decheng Capital Management III Cayman LLC acquired a new position in BeyondSpring in the first quarter valued at approximately $10,908,000. BlackRock Inc. raised its position in shares of BeyondSpring by 20.8% during the first quarter. BlackRock Inc. now owns 1,861,219 shares of the company's stock worth $4,095,000 after purchasing an additional 320,428 shares during the period. State Street Corp raised its position in shares of BeyondSpring by 11.5% during the first quarter. State Street Corp now owns 563,670 shares of the company's stock worth $1,240,000 after purchasing an additional 57,933 shares during the period. Renaissance Technologies LLC raised its position in shares of BeyondSpring by 831.9% during the first quarter. Renaissance Technologies LLC now owns 282,373 shares of the company's stock worth $621,000 after purchasing an additional 252,073 shares during the period. Finally, BNP Paribas Arbitrage SA raised its position in shares of BeyondSpring by 19.6% during the first quarter. BNP Paribas Arbitrage SA now owns 131,477 shares of the company's stock worth $289,000 after purchasing an additional 21,587 shares during the period. 23.35% of the stock is owned by institutional investors and hedge funds.
其他几家机构投资者最近也增持或减持了该公司的股份。德诚资本管理III开曼有限责任公司在第一季度收购了万春医药的一个新头寸,价值约10,908,000美元。今年第一季度,贝莱德将其在万春医药的持仓比例提高了20.8%。贝莱德股份有限公司在此期间增持了320,428股,目前持有1,861,219股该公司股票,价值4,095,000美元。道富银行今年第一季度将其在万春医药的持仓比例提高了11.5%。道富银行目前持有563,670股该公司股票,价值1,240,000美元,在此期间又购买了57,933股。复兴科技股份有限公司在第一季度将其在万春医药的持股比例提高了831.9%。复兴科技有限责任公司现在拥有282,373股该公司的股票,价值621,000美元,在此期间又购买了252,073股。最后,法国巴黎银行套利公司在第一季度将其在万春医药的持仓提高了19.6%。法国巴黎银行套利公司现在持有131,477股该公司股票,价值28.9万美元,在此期间又购买了21,587股。23.35%的股票由机构投资者和对冲基金持有。
BeyondSpring Stock Down 4.4 %
万春医药股价下跌4.4%
Shares of NASDAQ:BYSI opened at $0.97 on Wednesday. BeyondSpring Inc. has a twelve month low of $0.94 and a twelve month high of $17.98. The stock's 50 day moving average is $1.40 and its 200-day moving average is $1.62. The firm has a market capitalization of $37.95 million, a price-to-earnings ratio of -0.59 and a beta of 1.03.
纳斯达克:比亚迪周三开盘报0.97美元。万春医药股价跌至0.94美元的12个月低点和17.98美元的12个月高点。该股的50日移动均线切入位在1.40美元,200日移动均线切入位在1.62美元。该公司的市值为3795万美元,市盈率为-0.59倍,贝塔系数为1.03。
About BeyondSpring
关于万春医药
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer.
万春医药是一家临床期生物制药公司,与其子公司一起专注于癌症疗法的开发。该公司的主要资产是普利布林,这是一种选择性免疫调节微管结合剂,已经完成了预防化疗引起的中性粒细胞减少症和治疗晚期非小细胞肺癌的第三阶段临床试验。
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on BeyondSpring (BYSI)
- Defensive Stocks For A Volatile Market
- SunPower Is Ready To Power Up Triple-Digit Earnings Gains
- Will UPS Be Next to Deliver a Warning?
- Is This the Darkest Before the Dawn for Gap Stock?
- Build A Better Tech Portfolio With Jabil Inc.
- 在新浪万春医药上免费获取斯托克新闻网的研究报告
- 防御性股票应对动荡的市场
- SunPower准备推动三位数的收益增长
- UPS会成为下一个发出警告的公司吗?
- 这是Gap Stock黎明前最黑暗的一次吗?
- 与捷普公司一起打造更好的技术产品组合。
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
接受万春医药日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收最新新闻和分析师对万春医药及相关公司评级的每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧